Page last updated: 2024-08-17

penicillanic acid and Neutropenia

penicillanic acid has been researched along with Neutropenia in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (18.07)	18.2507
2000's	42 (50.60)	29.6817
2010's	25 (30.12)	24.3611
2020's	1 (1.20)	2.80

Authors

Authors	Studies
Cuellar-Pompa, L; Lede, R; Rosanova, MT	1
Cassisa, V; Coron, N; Eveillard, M; Godefroy, A; Joly-Guillou, ML; Kempf, M; Marion, E; Marsollier, L; Pailhoriès, H; Pavlickova, S	1
Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J	1
Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK	1
Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T	1
Abouchahla, W; Courcol, R; Delebarre, M; Delvallée, M; Dessein, R; Kipnis, E; Mazingue, F; Wallet, F	1
Balm, M; Carter, J; Humble, M; Moniwa, A; Roohullah, A; Weinkove, R; Wood, C	1
Burke, MJ; Pratt, JA; Stricherz, MK; Verghese, PS	1
Arisoy, ES; Corapcioglu, F; Demirsoy, U; Karadogan, M; Karakurt, DG; Oncel, S	1
Bergeron, L; Grégoire, JP; Lemieux, P; Thibeault, R	1
Cies, JJ; Jain, J; Kuti, JL	1
Gardner, JH; Hahn, U; Lehman, S; Peake, SL; Roberts, JA; Roberts, MS; Sime, FB; Tiong, IS; Warner, MS	1
Bang, JH; Bang, SM; Choe, PG; Kim, CJ; Kim, ES; Kim, HB; Kim, M; Kim, NH; Kim, NJ; Lee, JO; Nam, EY; Oh, MD; Park, SW; Park, WB; Song, KH	1
Monogue, ML; Nicolau, DP	1
Iguchi, A; Kaneda, M; Kobayashi, K; Kobayashi, R; Sato, T; Yasuda, K	1
Iguchi, A; Kaneda, M; Kobayashi, R; Nakajima, M; Sato, T	1
Hazar, V; Karasu, GT; Ogunc, D; Uygun, V; Yesilipek, A	1
Hu, LD; Huang, XJ; Jia, JS; Li, J; Lu, KY; Wang, C; Wu, DP	1
Erdem, E; Gulec, SG; Kebudi, R; Vural, S; Yildirmak, Y	1
Bastús, R; Cirera, L; Estany, C; Estrada, C; Garau, J; Gómez, I; Gómez, L; Márquez, M; Martí, JM; Quintana, S	1
Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N	1
Bivas, A; Fraser, A; Leibovici, L; Paul, M; Yahav, D	1
Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D	1
Kılıç, SC; Sarper, N; Zengin, E	1
Emecen, M; Erdem, E; Karaman, S; Kebudi, R; Vural, S; Yildirmak, Y	1
Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M	1
Ay, H; Hatipoglu, M; Mutluoglu, M; Onem, Y; Turhan, V; Uzun, G	1
Danbara, M; Higashihara, M; Horie, R; Ishii, R; Kamata, H; Kimura, H; Miyazaki, K; Okina, S; Osaka, M	1
Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B	1
Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H	1
Jones, RN; Mutnick, AH; Turner, PJ	1
Fixson, A; Glasmacher, A; Gorschlüter, M; Hahn, C; Horré, R; Marklein, G; Mey, U; Molitor, E; Sauerbruch, T; Schmidt-Wolf, IG; Ziske, C	1
Akan, H; Calandra, T; Cometta, A; Crokaert, F; De Bock, R; Engelhard, D; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Korten, V; Marchetti, O; Padmos, A; Paesmans, M; Skoutelis, A; Vandenbergh, M; Vandercam, M; Viscoli, C; Zinner, S	1
Arjona, R; Pena, MA; Peralta, FG; Roíz, MP; Sánchez, MB; Tejero, MA	1
Glasmacher, A; Wade, JC	1
Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T	1
Auvrignon, A; Le Guyader, N; Leverger, G; Portier, E; Tabone, MD; Vu-Thien, H	1
Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K	1
Giltri, G; Isella, M; Larocca, A; Marinoni, S; Miccolis, I; Parma, M; Pogliani, EM; Rossini, F; Terruzzi, E; Verga, L	1
Farga, A; Faus, F; Gimeno, C; Gómez, C; Goterris, R; Gutierrez, A; Martinez, F; Muñoz, I; Navarro, D; Solano, C	1
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C	1
Bordigoni, P; Chastagner, P; Fouyssac, F; Mansuy, L; Salmon, A; Schmitt, C	1
Bellaire, T; Cornely, OA; Dörken, B; Einsele, H; Krause, S; Kubin, T; Maschmeyer, G; Reich, G; Sandherr, M; Thiel, E	1
Berman, D; Bode, RS; Brachlow, AE; Capouya, JD; Enrione, MA; Forrster, EE; Fuh, BR; Pourrat, M	1
Fraser, A; Leibovici, L; Paul, M; Yahav, D	1
Benner, A; Egerer, G; Geiss, HK; Goldschmidt, H; Harter, C; Ho, AD; Hoppe-Tichy, T; Schulze, B	1
Bock, R; Calandra, T; Cometta, A; Crokaert, F; Glauser, MP; Kern, WV; Paesmans, M; Viscoli, C	1
Aydogdu, I; Ersoy, Y; Kaya, E; Kuku, I; Serefhanoglu, K; Serefhanoglu, S	1
Bow, EJ; Laverdiere, M; Noskin, GA; Rotstein, C; Sanche, S; Schwarer, AP; Segal, BH; Seymour, JF; Szer, J	1
Alexaki, P; Christakis, GB; Megalakaki, A; Perlorentzou, S; Zarkadis, IK	1
Carreras, E; Fernández-Avilés, F; Gallego, C; García, L; Gaya, A; González, M; Granell, M; Hernando, A; Martínez, C; Montserrat, E; Ramiro, L; Rovira, M; Segura, S; Urbano-Ispizua, A; Valverde, M	1
Ammann, RA; Bode, U; Engelhart, S; Fleischhack, G; Gröger, N; Hasan, C; Kramer, MH; Simon, A; Wilkesmann, A; Wiszniewsky, G	1
Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA	1
Dilay, L; Gin, A; Karlowsky, JA; Rubinstein, E; Walkty, A; Zhanel, GG	1
Alhambra, A; Cuétara, MS; del Palacio, A; Moreno, JM; Ortiz, MC; Pontón, J	1
Bode, U; Fleischhack, G; Groll, AH; Laws, HJ; Lehrnbecher, T; Molitor, E; Simon, A; Tramsen, L; Wieland, R	1
Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Mocchegiani, F; Orlando, F; Riva, A; Rocchi, M; Saba, V; Scalise, G; Silvestri, C	1
Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM	1
Aytac, S; Cengiz, AB; Cetin, M; Ceyhan, M; Secmeer, G; Tuncer, M; Yetgin, S; Yildirim, I	1
Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F	1
Cony-Makhoul, P; Fière, D; Guy, H; Herbrecht, R; Marie, JP; Milpied, N; Pico, JL; Plantier, I; Vekhoff, A	1
Wise, R	1
Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M	1
Gerber, L; Wing, EJ	1
Aguirre, C; Barreiro, G; Ruiz-Irastorza, G	1
Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G	1
Dickinson, JP; Graham, J; Hazel, DL; Kelsey, SM; Newland, AC	1
Böhme, A; Hoelzer, D; Shah, PM; Stille, W	1
Dudley, MN; Okereke, C	1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A	1
Böhme, C; Hess, U; Rey, K; Senn, HJ	1
Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R	1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P	1
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I	1
Bradley, SJ	1
Arranz, R; de La Cámara, R; Font, P; Leyra, F; María Fernández Rañada, J; Pajuelo, F; Rivero, N	1
Bode, U; Fleischhack, G; Hasan, C; Havers, W; Marklein, G; Schmidt-Niemann, M; Wulff, B	1
Bucaneve, G; D'Antonio, D; Del Favero, A; Furno, P; Gentile, G; Mandelli, F; Martino, B; Martino, P; Menichetti, F; Micozzi, A; Ricci, P; Russo, D	1
Bauduer, F; Boiron, JM; Boulat, O; Cousin, T; Fegueux, N; Jourdan, E; Molina, L; Reiffers, J; Rigal-Huguet, F	1
Plosker, GL; Young, M	1
Cassone, M; Falcone, M; Paris, A; Pavoni, G; Pistella, E; Venditti, M	1
Batlle, M; Benlloch, L; Capote, FJ; Gutiérrez, M; Jarque, I; Julià, A; Lahuerta, JJ; Larrea, L; López, J; Palau, J; Pérez, C; Ramos, F; Rovira, M; Sanz, MA; Vázquez, L	1
Kelsey, SM; Newland, AC; Pocock, CE; Shaw, E; Weinhardt, B	1

Reviews

8 review(s) available for penicillanic acid and Neutropenia

Article	Year
[Efficacy and safety of empirical treatment with piperacillin/tazobactan as monotherapy in episodes of neutropenia and fever in children with cancer: systematic review and meta-analysis]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2021, Volume: 38, Issue:4 Topics: Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin	2021
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. The Cochrane database of systematic reviews, 2010, Nov-10, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Fever; Humans; Imipenem; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Thienamycins	2010
[Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination]. Medecine et maladies infectieuses, 2005, Volume: 35, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2005
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enzyme Inhibitors; Fever; Humans; Neutropenia; Penicillanic Acid; Penicillins; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome	2006
Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Soft Tissue Infections	2007
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host. The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Models, Biological; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam	1998
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections. PharmacoEconomics, 2001, Volume: 19, Issue:11 Topics: Bacterial Infections; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Economics, Pharmaceutical; Hospitalization; Humans; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2001
[Piperacillin-tazobactam in the treatment of severe nosocomial infections]. Recenti progressi in medicina, 2002, Volume: 93, Issue:3 Topics: Bacteria; beta-Lactamase Inhibitors; Clinical Trials as Topic; Costs and Cost Analysis; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Tazobactam	2002

Trials

48 trial(s) available for penicillanic acid and Neutropenia

Article	Year
Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients? Pediatric hematology and oncology, 2014, Volume: 31, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cytokines; Female; Fever; Humans; Infant; Inflammation Mediators; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Risk Factors	2014
Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia. Pediatric blood & cancer, 2015, Volume: 62, Issue:3 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Female; Fever; Humans; Male; Models, Biological; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections	2015
Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:8 Topics: Anti-Bacterial Agents; Drug Monitoring; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; New Zealand; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Time Factors; Treatment Outcome	2015
A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. Pediatric blood & cancer, 2008, Volume: 51, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefozopran; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Prospective Studies; Survival Rate	2008
Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:4 Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Infant, Newborn; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Severity of Illness Index; Sulbactam	2009
Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study. Pediatric blood & cancer, 2009, Volume: 53, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies	2009
[Clinical effects and safety of piperacillin/tazobactam in treating neutropenic febrile patients with malignant hematopathy]. Zhonghua yi xue za zhi, 2009, Jan-06, Volume: 89, Issue:1 Topics: Adult; Anti-Bacterial Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome	2009
Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia. Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies	2010
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poisoning; Prospective Studies; Treatment Outcome; Young Adult	2010
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult	2010
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia. Pediatric blood & cancer, 2011, Dec-15, Volume: 57, Issue:7 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2011
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia. Pediatric hematology and oncology, 2011, Volume: 28, Issue:4 Topics: Acute Disease; Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Leukemia; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult	2011
Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia. Pediatric blood & cancer, 2012, Volume: 58, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Time Factors	2012
[Efficacy and safety of piperacillin-tazobactam for febrile neutropenic patients in Japan]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:7 Topics: Anti-Bacterial Agents; Female; Fever; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome	2012
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors. Pediatric hematology and oncology, 2013, Volume: 30, Issue:2 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam	2013
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. PloS one, 2013, Volume: 8, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins	2013
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Treatment Outcome	2003
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Aug-01, Volume: 37, Issue:3 Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin	2003
Vancomycin does not benefit persistently febrile neutropenic people with cancer. Cancer treatment reviews, 2004, Volume: 30, Issue:1 Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin	2004
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome	2004
Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:10 Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Follow-Up Studies; Humans; Infant; Male; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Recurrence; Tazobactam; Treatment Outcome	2004
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Pediatric hematology and oncology, 2004, Volume: 21, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins	2004
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:6 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2005
Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin-tazobactam. Bone marrow transplantation, 2005, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Amphotericin B; Bacteremia; Bacterial Infections; Female; Fever; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Matched-Pair Analysis; Middle Aged; Neutropenia; Penicillanic Acid; Peripheral Blood Stem Cell Transplantation; Piperacillin; Piperacillin, Tazobactam Drug Combination; Premedication; Transplantation, Autologous	2005
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study. Current medical research and opinion, 2005, Volume: 21, Issue:5 Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome	2005
Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial. British journal of haematology, 2005, Volume: 130, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Thienamycins	2005
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial. Bone marrow transplantation, 2006, Volume: 37, Issue:4 Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia; Penicillanic Acid; Peripheral Blood Stem Cell Transplantation; Piperacillin; Predictive Value of Tests; Prospective Studies; Survival Rate; Tazobactam; Transplantation, Autologous; Treatment Outcome	2006
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Enzyme Inhibitors; Europe; Fever; Hematologic Neoplasms; Humans; Infant; Injections, Intravenous; Middle Aged; Middle East; Neutropenia; North America; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome	2006
Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia. Annals of the Academy of Medicine, Singapore, 2006, Volume: 35, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Risk Assessment; Risk Factors; Tazobactam; Thienamycins	2006
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2006
Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-20, Volume: 24, Issue:30 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Busulfan; Ceftriaxone; Female; Fever; Health Care Costs; Hematologic Neoplasms; Home Care Services; Hospital Charges; Humans; Inpatients; Male; Middle Aged; Neutropenia; Patient Readmission; Penicillanic Acid; Piperacillin; Stem Cell Transplantation; Tazobactam; Transplantation, Autologous	2006
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Singapore medical journal, 2008, Volume: 49, Issue:1 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2008
Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Pediatric hematology and oncology, 2008, Volume: 25, Issue:4 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Precursor Cell Lymphoblastic Leukemia-Lymphoma	2008
[Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles]. Presse medicale (Paris, France : 1983), 1995, Feb-25, Volume: 24, Issue:8 Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam	1995
The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia. The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A Topics: Abdomen; Adult; Bacteremia; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Skin Diseases, Infectious; Tazobactam	1993
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin	1993
Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies. Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; beta-Lactamase Inhibitors; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	1997
Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study. European journal of medical research, 1998, Jul-20, Volume: 3, Issue:7 Topics: Anti-Infective Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Neutropenia; Penicillanic Acid; Pilot Projects; Piperacillin; Prognosis; Prospective Studies; Tazobactam	1998
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients. The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin	1998
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:4 Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Ceftazidime; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome	1998
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:2 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin	1999
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. Haematologica, 1999, Volume: 84, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin	1999
[Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)]. Medicina clinica, 2001, May-05, Volume: 116, Issue:16 Topics: Adolescent; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2001
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Gentamicins; Germany; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Sulbactam; Tazobactam; Treatment Outcome	2001
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Oct-15, Volume: 33, Issue:8 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome	2001
A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia. Leukemia & lymphoma, 2001, Volume: 42, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Cefpirome; Cephalosporins; Enzyme Inhibitors; Female; Fever; France; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome	2001
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1 Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome	2002
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy. Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; beta-Lactamase Inhibitors; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam	1992

Other Studies

27 other study(ies) available for penicillanic acid and Neutropenia

Article	Year
Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia. Future microbiology, 2017, Volume: 12 Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Translocation; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Gastrointestinal Tract; Immunosuppression Therapy; Lung; Mice; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial	2017
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia. International journal of antimicrobial agents, 2018, Volume: 51, Issue:1 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus	2018
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study. BMC infectious diseases, 2017, 07-17, Volume: 17, Issue:1 Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins	2017
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study. Lung cancer (Amsterdam, Netherlands), 2017, Volume: 113 Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam	2017
Optimization of continuous infusion of piperacillin-tazobactam in children with fever and neutropenia. The Pediatric infectious disease journal, 2013, Volume: 32, Issue:9 Topics: Adolescent; Anti-Bacterial Agents; Child; Female; Fever of Unknown Origin; Humans; Infusions, Intravenous; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Treatment Outcome	2013
Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults. Internal medicine journal, 2013, Volume: 43, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Drug Substitution; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Young Adult	2013
Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population. Pediatric blood & cancer, 2014, Volume: 61, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Diseases; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis	2014
Higher risk of neutropenia associated with piperacillin-tazobactam compared with ticarcillin-clavulanate in children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jan-15, Volume: 60, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clavulanic Acids; Cohort Studies; Female; Humans; Infant; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Ticarcillin	2015
Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 44 Topics: Adult; Aged; Antineoplastic Agents; Ceftazidime; Drug Resistance, Microbial; Female; Fever; Fungi; Gram-Negative Bacteria; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin	2016
In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Colistin; Culture Media; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tobramycin; Treatment Outcome	2016
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward]. Harefuah, 2010, Volume: 149, Issue:12 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome	2010
Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection. Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:1 Topics: Aged; Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Diabetic Foot; Fever; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thrombocytopenia	2013
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins	2002
Incidence of neutropenia during treatment of bone-related infections with piperacillin-tazobactam. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Dec-01, Volume: 37, Issue:11 Topics: Age Factors; Aged; Drug Therapy, Combination; Female; Fever; Humans; Incidence; Male; Middle Aged; Neutropenia; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2003
Index of suspicion. Pediatrics in review, 2005, Volume: 26, Issue:9 Topics: Acidosis; Adolescent; Appendectomy; Appendicitis; beta-Lactamase Inhibitors; Child; Comorbidity; Diagnosis, Differential; Ethylene Glycol; Female; Humans; Infant; Leukopenia; Male; Metabolism, Inborn Errors; Neutropenia; Osteomyelitis; Pelvic Inflammatory Disease; Penicillanic Acid; Poisoning; Tazobactam	2005
Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece. Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 8 Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bacteremia; Base Sequence; Catheterization, Central Venous; Cytarabine; Humans; Leukemia, Myeloid; Male; Methylobacteriaceae; Molecular Sequence Data; Neutropenia; Penicillanic Acid; Phylogeny; Piperacillin; Piperacillin, Tazobactam Drug Combination; RNA, Bacterial; RNA, Ribosomal, 16S; Vidarabine	2006
Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Fosfomycin; Glycopeptides; Humans; Infant; Length of Stay; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Teicoplanin; Treatment Outcome	2006
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2007, Volume: 39, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors	2007
False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam. Revista iberoamericana de micologia, 2007, Volume: 24, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Artifacts; Aspergillosis; Biomarkers; Combined Modality Therapy; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Female; Fungemia; Galactose; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mannans; Middle Aged; Mucositis; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity	2007
Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:11 Topics: Bacterial Infections; Fever of Unknown Origin; Humans; Hypersensitivity; Infant; Infant, Newborn; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Withholding Treatment	2007
Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis. Peptides, 2008, Volume: 29, Issue:1 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; DNA-Binding Proteins; Drug Synergism; Enterococcus faecalis; Escherichia coli; Granulocyte Colony-Stimulating Factor; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Peptides, Cyclic; Peritonitis; Piperacillin; Survival Rate; Tazobactam; Time Factors	2008
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients]. Pathologie-biologie, 1995, Volume: 43, Issue:4 Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins	1995
Life-threatening neutropenia secondary to piperacillin/tazobactam therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:4 Topics: Adult; Drug Therapy, Combination; Humans; Male; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam	1995
Reversible bone marrow depression by high-dose piperacillin/tazobactam. British journal of haematology, 1996, Volume: 95, Issue:4 Topics: Adolescent; Body Weight; Bone Marrow Diseases; Drug Therapy, Combination; Female; Fever; Humans; Neutropenia; Pancytopenia; Penicillanic Acid; Piperacillin; Tazobactam; Weight Loss	1996
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF. Hematology and cell therapy, 1997, Volume: 39, Issue:2 Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam	1997
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:2 Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin	2000
Control of glycopeptide-resistant enterococci in an oncology unit. Pharmacotherapy, 2000, Volume: 20, Issue:9 Pt 2 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Glycopeptides; Humans; Infection Control; Neoplasms; Neutropenia; Oncology Service, Hospital; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome	2000